Medsir

We track 3 ClinicalTrials.gov studies led by Medsir. The portfolio skews toward Phase 2 (2 trials).

3 clinical trials sponsored by Medsir.

Pipeline by Phase

PhaseTrialsDistribution
Phase 2 2
67%
Phase 3 1
33%

Trial Status Breakdown

Trials by Medsir

PHASE IB/II STUDY TO EVALUATE SAFETY AND PRELIMINARY EFFICACY OF ZANIDATAMAB IN COMBINATION WITH TUCATINIB AND CHEMOTHERAPY (CAPECITABINE OR ERIBULIN MESYLATE) IN HER2-POSITIVE ADVANCED BREAST CANCER

NCT07494448 · NOT YET RECRUITING · Phase 2

A Randomized Phase II Study to Evaluate the Safety and Efficacy of Trastuzumab Deruxtecan Versus CDK4/6 Inhibitor-based Endocrine Therapy as First-line Therapy of HR-positive and HER2-low/Ultralow Advanced Breast Cancer Patients Classified as Non-luminal Subtype According to Gene Expression Profiling.

NCT06486883 · RECRUITING · Phase 2

A Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Elacestrant Plus Everolimus Versus Elacestrant in Patients With ER+/HER2-, ESR1mut Advanced Breast Cancer Progressing to Endocrine Therapy and CDK4/6 Inhibitors

NCT06382948 · RECRUITING · Phase 3

Frequently Asked Questions

How many clinical trials does Medsir sponsor?

Medsir currently sponsors 3 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 3.

What conditions does Medsir research?

Medsir conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Medsir recruiting for clinical trials?

Yes, Medsir currently has 2 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More